{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Advair+250", "query": { "intervention": "Advair 250" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 36, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Advair+250&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-20T05:10:25.830Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00346749", "title": "ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Salmeterol", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol Combination Product", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 180, "start_date": "2006-12", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2016-10-28", "last_synced_at": "2026-09-20T05:10:25.830Z", "location_count": 11, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Diego, California + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Fort Collins", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00346749" }, { "nct_id": "NCT00568347", "title": "Evaluation Inhaled Corticosteroids on Exhaled Nitric Oxide Gas Exchange", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "COPD" ], "interventions": [ { "name": "fluticasone 100mcg/ salmeterol 50mcg", "type": "DRUG" }, { "name": "fluticasone 250/salmeterol 50", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" }, { "name": "salmeterol and fluticasone propionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arthur F Gelb MD", "sponsor_class": "INDIV", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "20 Years to 85 Years" }, "enrollment_count": 39, "start_date": "2006-01", "completion_date": "2013-10", "has_results": false, "last_update_posted_date": "2015-03-17", "last_synced_at": "2026-09-20T05:10:25.830Z", "location_count": 1, "location_summary": "Lakewood, California", "locations": [ { "city": "Lakewood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00568347" }, { "nct_id": "NCT00403286", "title": "A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Fluticasone Propionate/Formoterol Fumarate", "type": "DRUG" }, { "name": "Fluticasone Propionate", "type": "DRUG" }, { "name": "Formoterol Fumarate", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol Xinafoate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dey", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 457, "start_date": "2006-11", "completion_date": "2007-05", "has_results": false, "last_update_posted_date": "2009-06-30", "last_synced_at": "2026-09-20T05:10:25.830Z", "location_count": 49, "location_summary": "Birmingham, Alabama • Jasper, Alabama • Phoenix, Arizona + 44 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Buena Park", "state": "California" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00403286" }, { "nct_id": "NCT01437995", "title": "Long-acting Beta Agonist Step Down Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone/Salmeterol Diskus", "type": "DRUG" }, { "name": "Fluticasone Diskus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 459, "start_date": "2012-03", "completion_date": "2015-10", "has_results": true, "last_update_posted_date": "2017-04-25", "last_synced_at": "2026-09-20T05:10:25.830Z", "location_count": 19, "location_summary": "Tucson, Arizona • San Diego, California • Denver, Colorado + 15 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01437995" }, { "nct_id": "NCT02175771", "title": "Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Persistent Asthma" ], "interventions": [ { "name": "Fp MDPI", "type": "DRUG" }, { "name": "FS MDPI", "type": "DRUG" }, { "name": "FLOVENT HFA", "type": "DRUG" }, { "name": "ADVAIR DISKUS", "type": "DRUG" }, { "name": "albuterol/salbutamol HFA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 758, "start_date": "2014-07", "completion_date": "2015-07", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-09-20T05:10:25.830Z", "location_count": 101, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Pell City, Alabama + 85 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Pell City", "state": "Alabama" }, { "city": "Little Rock", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02175771" }, { "nct_id": "NCT00974246", "title": "The Effect on Depressive Symptoms in ECF Residents With COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Obstructive Pulmonary Disease", "Depression" ], "interventions": [ { "name": "Advair diskus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Valley Medical Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "94 Years", "sex": "ALL", "summary": "18 Years to 94 Years" }, "enrollment_count": 30, "start_date": "2009-10", "completion_date": "2011-07", "has_results": true, "last_update_posted_date": "2016-12-28", "last_synced_at": "2026-09-20T05:10:25.830Z", "location_count": 2, "location_summary": "Brooksville, Florida • Centerville, Ohio", "locations": [ { "city": "Brooksville", "state": "Florida" }, { "city": "Centerville", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00974246" }, { "nct_id": "NCT00633217", "title": "Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Fluticasone Propionate/Salmeterol DISKUS 250/50mcg", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a MDI 230/42mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 247, "start_date": "2008-03", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2016-12-08", "last_synced_at": "2026-09-20T05:10:25.830Z", "location_count": 16, "location_summary": "Jasper, Alabama • Mobile, Alabama • Lafayette, Louisiana + 13 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Lafayette", "state": "Louisiana" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Sunset", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00633217" }, { "nct_id": "NCT00452348", "title": "A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Propionate/salmeterol xinofoate 250/50 mcg BID", "type": "DRUG" }, { "name": "Fluticasone propionate 250 mcg BID", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 628, "start_date": "2007-05", "completion_date": "2009-04", "has_results": true, "last_update_posted_date": "2016-12-09", "last_synced_at": "2026-09-20T05:10:25.830Z", "location_count": 58, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Fresno, California + 54 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Fresno", "state": "California" }, { "city": "Fullerton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00452348" }, { "nct_id": "NCT01817764", "title": "A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Umeclidinium/vilanterol", "type": "DRUG" }, { "name": "Fluticasone propionate/salmeterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 707, "start_date": "2013-03-01", "completion_date": "2013-10-25", "has_results": true, "last_update_posted_date": "2017-11-08", "last_synced_at": "2026-09-20T05:10:25.830Z", "location_count": 9, "location_summary": "Jasper, Alabama • Phoenix, Arizona • San Diego, California + 6 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01817764" }, { "nct_id": "NCT00741767", "title": "The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Obstructive Pulmonary Disease", "Sleep Disorders" ], "interventions": [ { "name": "salmeterol-fluticasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 0, "start_date": "2008-08", "completion_date": "2012-02", "has_results": false, "last_update_posted_date": "2015-10-06", "last_synced_at": "2026-09-20T05:10:25.830Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00741767" } ] }